By George Anderson
The National Food Processors Association (NFPA) is criticizing the Food and Drug Administration's (FDA) proposal for new labeling requirements for foods with trans fats.
The NFPA contends that qualitative or quantitative consumer research is needed before deciding if the reference "Intake of trans fat should be as low as possible" should be included on product labels.
Dr. Rhona Applebaum, executive vice president, NFPA said changing the labeling requirements will, "mislead consumers to consider this dietary component out of balance with overall dietary recommendations in general, and with dietary fat components in particular. Consumers would be likely to avoid trans fats at all costs, with the strong potential of distorting dietary intakes in unhealthful ways. Thus, the net effect of the proposed trans fat Daily Value footnote is likely to be harmful."
Moderator's Comment: What is your position on the FDA's proposed trans fat labeling requirements?
As we understand, there is no amount of acceptable trans fat consumption. Dr. Applebaum may be right that the FDA proposal may lead some to overlook other nutritional dangers. We think, however, her argument would go over better with consumers if similar substances of no nutritional value were included on labels. Of course, if Dr. Applebaum did that she would be out of a job. [George Anderson - Moderator]